Patents
Patents for C07D 339 - Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms (3,352)
05/1998
05/26/1998US5756729 Multistep economical process starting from 2-amino-5-chloro-2*-fluorobenzophenone
05/26/1998US5756706 Chemical intermediates
05/26/1998US5756533 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
05/14/1998WO1998001440A3 Anti-viral pharmaceutical compositions containing saturated 1,2-dithiaheterocyclic compounds and uses thereof
05/12/1998US5750560 Therapeutic compositions based on 1,2-dithiole-3-thione derivatives
05/07/1998WO1998018751A1 Presentation of bioactives
05/05/1998US5747542 Oxo-substituted tetrahydronaphthalene derivatives having retinold and/or retinoid antagonist-like biological activity
05/05/1998CA2152350C Reduction of hair growth employing sulfhydryl reactive compounds
04/1998
04/30/1998WO1998017630A1 Amide derivatives and their use as pesticides
04/28/1998US5744596 Antivirus agent
04/23/1998DE19642863A1 Amide Amides
04/22/1998CN1179778A Herbicidal benzoyl derivatives
04/21/1998US5741896 O- or S- substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
04/15/1998EP0835874A2 A process for the manufacture of 8-chloro-6-(2-fluorophenyl)-1-methyl-4h-imidazo (1,5a)(1,4) benzodiazepine (midazolam)
04/15/1998EP0835251A1 Process for the production of lipoic acid
04/15/1998EP0799220A4 Polymerisable monomers and polymers
04/09/1998WO1998014436A1 4,4-disubstituted-1,4-dihydro-2h-3,1-benzoxazin-2-ones useful as hiv reverse transcriptase inhibitors and intermediates and processes for making the same
04/09/1998WO1998014418A1 Liquid crystal compounds having negative permittivity, liquid crystal compositions, and liquid crystal display device
04/09/1998CA2268953A1 4,4-disubstituted-1,4-dihydro-2h-3,1-benzoxazin-2-ones useful as hiv reverse transcriptase inhibitors and intermediates and processes for making the same
04/08/1998EP0834503A1 Tetrahydrophthalimides, their preparation and use
04/01/1998EP0831793A1 Protein particles for therapeutic and diagnostic use
03/1998
03/25/1998CN1177346A Energy-activatable salt with fluorocarbon anions
03/24/1998US5731448 (+) and (-)-8-chloro-6-sulfonyloxy-octanoic acid, its derivatives, and methods for making
03/24/1998US5731364 Photoimageable compositions comprising multiple arylsulfonium photoactive compounds
03/18/1998EP0662004B1 Use of persistent free-radicals in magnetic resonance imaging
03/17/1998US5728735 Pharmaceutical composition containing R-α-lipoic acid or S-α-lipoic acid as active ingredient
03/03/1998US5723666 Oxime substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
03/03/1998US5723620 Acetylenes disubstituted with a 5 substituted tetrahydronaphthyl group and with an aryl or heteroaryl groups having retinoid-like biological activity
02/1998
02/18/1998EP0823897A1 Nicotinic acid esters and pharmaceutical compositions containing them
02/18/1998EP0823895A1 Fatty acid esters as bioactive compounds
02/18/1998EP0823889A1 1,3-propane diol derivatives as bioactive compounds
01/1998
01/29/1998WO1998003474A1 Glyoxylic acid derivatives
01/29/1998DE19629465A1 New alkyl glyoxylic acid amide derivatives
01/27/1998US5712093 RXR homodimer formation
01/15/1998WO1998001442A1 Dithiole compounds, compositions containing them, and their use as antimicrobial and antifouling agents
01/15/1998WO1998001441A1 Dithiole compounds, compositions containing them, and their use as an antimicrobial and antifouling agents
01/15/1998WO1998001440A2 Anti-viral pharmaceutical compositions containing saturated 1,2-dithiaheterocyclic compounds and uses thereof
01/15/1998CA2260128A1 Anti-viral pharmaceutical compositions containing saturated 1,2-dithiaheterocyclic compounds and uses thereof
01/08/1998WO1998000411A1 Prenyl transferase inhibitors
01/08/1998CA2255893A1 Prenyl transferase inhibitors
01/06/1998US5705500 Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
01/06/1998US5705192 Fluidized beds and spraying then removal of solvent and forming tablets
12/1997
12/29/1997EP0813875A2 Inhibition of abnormal accumulation of extracellular matrices
12/29/1997EP0813542A1 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
12/29/1997EP0813521A1 Energy-activatable salts with fluorocarbon anions
12/29/1997EP0813519A1 Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
12/24/1997WO1997048672A2 Substituted tetrahydronaphthalene and dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
12/24/1997CA2258313A1 Substituted tetrahydronaphthalene and dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
12/23/1997US5700448 Contrast media
12/19/1997CA2208136A1 Inhibition of abnormal accumulation of extracellular matrices
12/17/1997EP0812590A2 Use of R-alpha lipoic acid for cytoprotection
12/16/1997US5698580 Antiviral agent containing benzodithiin derivative as active ingredient
12/13/1997CA2206219A1 A novel process for the manufacture of 8-chloro-6-(2-fluorophenyl)-1-methyl-4h-imidazo [1,5a] [1,4] benzodiazepine (midazolam)
12/10/1997EP0811005A1 Herbicidal benzoyl derivatives
12/10/1997EP0810998A1 Phenyl diketone derivatives
12/09/1997US5696254 Processes for the diastereoselective synthesis of nucleoside analogues
12/02/1997US5693827 Treatment of HIV infections and compounds useful therein
12/02/1997US5693787 Stereospecific
12/02/1997US5693664 Use of R-(+)-α-lipoic acid, R-(-)dihydrolipoic acid and metabolites in the form of the free acid or salts or esters or amides for the preparation of drugs for the treatment of diabetes mellitus as well as of its sequelae
11/1997
11/25/1997US5691379 Dihydrolipoic acid as an ophthalmological agent to suppress intolerance reactions in the area between implants and living body tissue
11/20/1997WO1997043274A1 Improved reservoir components
11/20/1997CA2254072A1 Improved reservoir components
11/19/1997CN1165508A Synthesis of 35S-labeled oligonucleotides with 3H-1,2-benzodithiol-3-1,1-dioxide
11/05/1997EP0804430A1 Synthesis of optically pure 4-alkenyl- or 4-alkanyl-2-hydroxytetronic acids
10/1997
10/29/1997EP0803504A2 The process of producing polythiol oligomer
10/21/1997US5679697 Palladium complexes and methods for using same in the treatment of tumors
10/15/1997EP0800517A1 Acetylenes disubstituted with a 5 or 8 substituted tetrahydronaphthyl or dihydronaphthyl group and with an aryl or heteroaryl groups having retinoid-like biological activity
10/14/1997US5676884 Nonlinear optical materials containing polar disulfone-functionalized molecules
10/09/1997WO1997036863A1 Bisarylcyclobutene derivates as cyclooxygenase inhibitors
10/09/1997CA2250350A1 Bisarylcyclobutene derivates as cyclooxygenase inhibitors
10/08/1997EP0799220A1 Polymerisable monomers and polymers
10/08/1997CN1161332A Method for synthesizing thioctic acid amide
10/02/1997WO1997035929A1 Cationically polymerizable compositions capable of being applied by electrostatic assistance
10/02/1997DE19612687A1 New di:oxo:cyclohexyl:carbonyl-oxathiin or -dithiin derivatives
10/02/1997CA2250199A1 Cationically polymerizable compositions capable of being applied by electrostatic assistance
09/1997
09/30/1997US5672619 Fungicidal active compound combinations
09/23/1997US5670657 Disulfide cyclic compound for precious metal adhesives
09/23/1997CA2069024C Processes for the diastereoselective synthesis of nucleosides
09/17/1997CN1159800A 2-aroylcyclohexandiones, process for preparing the same and their use as herbicides or plant growth regulators
09/16/1997US5668168 1,2-dithiin antiinfective agents
09/03/1997EP0792878A2 Geminal carboxylic acids and esters thereof, pharmaceutical formulations containing them useful in the treatment of bone dysmetabolism
09/02/1997US5663320 Processes for the diastereoselective separation of nucleoside analogue synthetic intermediates
08/1997
08/28/1997WO1997030986A1 2-hetaroylcyclohexane-1,3-diones
08/28/1997DE19607105A1 New di:oxo:cyclohexyl:carbonyl-oxathiin or -dithiin derivatives
08/27/1997EP0790965A1 Synthesis of ?35 s-labeled oligonucleotides with 3h-1,2-benzodithiol-3-1,1-dioxide
08/27/1997CA2198525A1 Geminal carboxylic acids and esters thereof, pharmaceutical formulations containing them useful in the treatment of bone dysmetabolism
08/26/1997US5661176 (2-one (or thione)-1,3-dithiole-4,5-diyl)-bis(thiomethylthiocyanate), compounds for use as antimicrobial and marine antifouling agents
08/06/1997CN1035555C Process for diastereoselective synthesis of nucleosides
08/06/1997CN1035539C Pesticidal composition comprising hydrazine derivative
08/05/1997US5654469 For treatment of skin disorders
07/1997
07/29/1997US5652321 Composition for optical materials and use thereof
07/23/1997EP0785187A2 Preparation and use of salts of 6,8-bis(amidiniumthio)octanoic acid
07/16/1997EP0783487A1 2-aroylcyclohexandiones, process for preparing the same and their use as herbicides or plant growth regulators
07/15/1997US5648514 Substituted acetylenes having retinoid-like biological activity
07/15/1997US5648503 Acetylenes disubstituted with a 5 substituted tetrahydronaphthyl group and with an aryl or heteroaryl group having retinoid-like biological activity
07/15/1997US5648354 1,2-dithiins having antifungal activity
07/15/1997CA2069063C Processes for the diastereoselective synthesis of nucleosides
07/09/1997EP0782750A1 Novel electroconductive composition
07/03/1997WO1997023476A1 HETEROCYCLYL-CONDENSED BENZOYLGUANIDINES, THEIR PRODUCTION AND USE AS INHIBITORS OF THE CELLULAR Na+/H+-ANTIPORTER
07/03/1997CA2241143A1 Heterocyclyl-condensed benzoylguanidines, their production and use as inhibitors of the cellular na+/h+-antiporter
1 ... 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 ... 34